NFKB1 and breast carcinoma: Notably, we sought to unravel the role of the MMP inhibitor and the NFkB-FLIP-caspase-8 signal in ANDR mediated anticancer effect in ovarian and breast cancers; which has not been reported to date according to our knowledge.